Skip to main content
Clinical Trials/ACTRN12609000384257
ACTRN12609000384257
Not yet recruiting
Phase 2

Heads Up: A Phase II trial of a radiotherapy-based intervention for depression and malnutrition in Head and Neck cancer patients.

Calvary Mater Newcastle0 sites70 target enrollmentMay 29, 2009

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Malnutrition and depression in Head and Neck Cancer during radiotherapy
Sponsor
Calvary Mater Newcastle
Enrollment
70
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 29, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Head and Neck Cancer, \>20 fractions of radiotherapy (non\-palliative).

Exclusion Criteria

  • Inability to read and/or write in English

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancer
JPRN-UMIN000010848ational Institute of Radiological Sciences20
Active, not recruiting
Phase 1
A study to investigate the effect of addition of metformin to standard treatment in patients with inoperable stage III non-small cell lung cancer.
EUCTR2017-004877-15-BEAntwerp University Hospital, Department Thoracic Oncology104
Active, not recruiting
Not Applicable
Ensayo clínico fase II randomizado de radioterapia torácica 3D frente a la combinación de radioterapia torácica 3D y erlotinib (Tarceva®) en pacientes con carcinoma no microcítico de pulmón localizado irresecable o localmente avanzado no susceptible de quimioterapiaCarcinoma no microcítico de pulmón localizado irresecable o localmente avanzado, no susceptible de quimioterapia. Tratamiento combinado de radioterápica torácica y erlotinib y terapia de mantenimiento con erlotinib en monoterapiaLocalized-unresectable or locally advanced non-small cell lung carcinoma, which is not candidate for chemotherapy treatment. Combined treatment of thoracic radiotherapy and sequential treatment with erlotinib as a single agent
EUCTR2005-004124-39-ESDr. Enrique Martínez López90
Recruiting
Not Applicable
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerbreast cancer
JPRN-UMIN000029478QST Hospital, National Institutes for Quantum and Radiological Sciences and Technology30
Recruiting
Phase 1
A phase I/II clinical trial of radical radiotherapy using carbon-ion beams with standard adjuvant therapy for early breast cancerBreast cancerD001943
JPRN-jRCTs032180154Karasawa Kumiko30